分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

重组人CD84/SLAMF5(His Avi标签)|Human CD84/SLAMF5(93588ES)

Recombinant Human CD84/SLAMF5 (His-Avi Tag)
分享
收藏
产品详情
FAQ
产品文档
已发表文献
产品应用
产品介绍

CD84, also known as Ly-9B and SLAMF5, is a type I transmembrane protein in the SLAM subgroup of the CD2 family. SLAM family proteins regulate multiple aspects of immune system function. Mature human CD84 consists of a 204 amino acid (aa) extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 99 aa cytoplasmic domain with two immunoreceptor tyrosine-based switch motifs (ITSMs). Alternate splicing generates a soluble ECD, an isoform that lacks the first Ig-like domain, and additional isoforms with deletions in the cytoplasmic domain. CD84 exhibits homophilic binding which is mediated by the N-terminal Ig-like domain. Ligation induces tyrosine phosphorylation in the cytoplasmic ITSMs which then recruit the signaling adaptor molecules SAP (SLAM‑associated protein) and EAT-2 (EWS/Fli1-activated transcript 2). CD84 is expressed as a 60-90 kDa molecule with extensive and cell type-specific glycosylation. It is widely expressed among hematopoietic cells including hematopoietic stem cells, myeloid cells (e.g. macrophages, monocytes, dendritic cells, granulocytes, and mast cells), platelets and megakaryocytes, and lymphocytes. Within the T cell lineage, CD84 is expressed on thymocytes, CD4-CD8- cells, single positive CD4 or CD8 cells, NKT cells, and on mouse but not human NK cells.

产品性质
产品特色

高纯度、高活性、低内毒素、高批间一致性

应用案例

产品数据
 

image.png

存储条件

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。

COA
已发表文献
产品应用

【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白

223

2026-08-31

【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白

240

2026-08-31

【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白

250

2026-08-31

【文献解读】Science 重磅成果:西湖大学团队攻克共价蛋白药物核心瓶颈,建立通用高通量速效蛋白筛选平台

445

2026-06-25

【技术讲解】信号通路系列 | Wnt/β-catenin信号通路:细胞的“信号转换器”与“命运规划师”

774

2026-04-29

【文献解读】EGFR信号通路的耐药新视角:当EGFR-TKI遇上免疫压力,肿瘤如何“金蝉脱壳”?

575

2026-04-29

【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白

1211

2026-04-21

【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点

912

2026-04-21

【应用方向】SIRP家族分子详解与产品选择指南

748

2026-04-21

【应用方向】OX40-OX40L共刺激轴的T细胞存活调控

822

2026-04-21

【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案

1102

2026-04-21

【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点

1013

2026-04-21

【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用

1635

2026-04-20

【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量

14776

2026-03-02

【技术讲解】细胞因子科学选型--常见问题解答

11379

2026-09-21

联系我们
购物车
客服
转染试用